HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mamta Parikh Selected Research
Mamta Parikh Research Topics
Disease
11
Neoplasms (Cancer)
03/2024 - 01/2017
7
Prostatic Neoplasms (Prostate Cancer)
03/2024 - 01/2017
5
Carcinoma (Carcinomatosis)
01/2023 - 10/2021
4
Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 06/2021
2
Neoplasm Metastasis (Metastasis)
02/2024 - 01/2023
2
Bone Resorption
02/2024 - 04/2023
2
Non-Muscle Invasive Bladder Neoplasms
01/2024 - 01/2022
2
Ataxia Telangiectasia (Louis Bar Syndrome)
01/2023 - 10/2021
2
Kidney Neoplasms (Kidney Cancer)
01/2022 - 06/2021
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2018
1
Hypoxia (Hypoxemia)
01/2023
1
Adenocarcinoma
06/2022
1
Turcot syndrome
06/2022
1
Microsatellite Instability
06/2022
1
Rectal Neoplasms (Rectal Cancer)
06/2022
1
Urinary Tract Infections (Urinary Tract Infection)
02/2022
1
Urolithiasis
02/2022
1
Neutropenia
10/2021
1
Thrombocytopenia (Thrombopenia)
10/2021
1
Breast Neoplasms (Breast Cancer)
01/2018
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017
1
Sleep Initiation and Maintenance Disorders (Insomnia)
09/2016
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2016
Drug/Important Bio-Agent (IBA)
4
Hormones (Hormone)
IBA
03/2024 - 01/2018
3
Androgens
IBA
03/2024 - 04/2023
3
orteronel
IBA
03/2024 - 04/2023
3
Biomarkers (Surrogate Marker)
IBA
02/2024 - 02/2022
3
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 06/2021
3
pembrolizumab
IBA
01/2023 - 12/2018
3
Platinum
IBA
01/2023 - 12/2018
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2020
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
03/2024 - 01/2022
2
collagen type I trimeric cross-linked peptide
IBA
02/2024 - 04/2023
2
pyridinoline
IBA
02/2024 - 04/2023
2
Collagen
IBA
02/2024 - 04/2023
2
Alkaline Phosphatase
IBA
02/2024 - 04/2023
2
Gemcitabine
FDA Link
10/2021 - 12/2018
1
bicalutamide (Casodex)
FDA Link
Generic
03/2024
1
Prostate-Specific Antigen (Semenogelase)
IBA
03/2024
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2023
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2023
1
Neuregulin-1 (Neuregulin 1)
IBA
01/2023
1
DNA (Deoxyribonucleic Acid)
IBA
01/2023
1
Checkpoint Kinase 1
IBA
01/2023
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023
1
olaparib
IBA
01/2023
1
Radium-223
IBA
01/2023
1
Radiopharmaceuticals
IBA
01/2023
1
seribantumab
IBA
01/2023
1
Serum Albumin
IBA
01/2023
1
Lipids
IBA
02/2022
1
Immunoconjugates (Immunoconjugate)
IBA
01/2022
1
Single-Stranded DNA (DNA, Single Stranded)
IBA
10/2021
1
berzosertib
IBA
10/2021
1
enfortumab vedotin
IBA
06/2021
1
atezolizumab
IBA
06/2021
1
Androgen Receptors (Androgen Receptor)
IBA
01/2021
1
abiraterone
IBA
01/2021
1
Niclosamide
FDA Link
01/2021
1
Prednisone (Sone)
FDA Link
Generic
01/2021
1
Docetaxel (Taxotere)
FDA Link
12/2018
1
Cytokines
IBA
01/2018
1
Trastuzumab (Herceptin)
FDA Link
01/2018
Therapy/Procedure
9
Therapeutics
03/2024 - 03/2016
5
Drug Therapy (Chemotherapy)
01/2023 - 09/2016
3
Castration
04/2023 - 01/2021
3
Immunotherapy
06/2022 - 06/2021
2
Combination Drug Therapy (Combination Chemotherapy)
01/2023 - 06/2022
1
Drug Tapering
10/2021
1
Radiotherapy
01/2017
1
Prostatectomy (Retropubic Prostatectomy)
01/2017